Skip to content
FY'25FY'24FY'23FY'22
Returns
Return on equity-30.2%+22.4pp-52.6%-22.0pp-30.6%+16.2pp-46.8%+106pp
Return on assets-28.1%+19.7pp-47.8%-20.5pp-27.4%+8.7pp-36.1%+43.2pp
Return on invested capital-42.6%+44.6pp-87.2%-40.9pp-46.3%
Liquidity
Current ratio19.7×+9.2×10.4×-4.6×15×+5.9×9.2×+6.2×
Quick ratio19.7×+9.2×10.4×-4.6×15×+5.9×9.2×+6.2×
Cash ratio1.9×-1.3×3.2×-2.3×5.6×+4.6×0.9×-2.0×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Per Share
Book value per share$1.36+39.2%$0.98+17.2%$0.83-49.9%$1.66+123%
Valuation
Market capitalization$1.61B+336%$368.19M+176%$133.31M-29.6%$189.4M+686%
Enterprise value$1.59B+374%$335.15M+227%$102.37M-42.1%$176.83M+1,505%
Price / book8.8×+5.1×3.7×+2.1×1.6×-0.1×1.8×+0.4×
Earnings yield-2.7%+10.3pp-13%+8.8pp-21.8%-6.4pp-15.4%+125pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Trevi Therapeutics, Inc.'s ratios come from?
Every ratio is computed from Trevi Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.